COPD and Asthma Devices Market Size, Share, Growth Analysis, By Product Type(Chronic Obstructive Pulmonary Disease (COPD) and Asthma), By Indication(Retail Pharmacies, Hospitals and Online Pharmacies), By Region - Industry Forecast 2024-2031

COPD and Asthma Devices Market was valued at USD 46.50 billion in 2022, and is poised to grow from USD 48.78 billion in 2023, to USD 71.52 Billion by 2031 at a CAGR of 4.90% during the forecast period (2024-2031).

Chronic obstructive pulmonary disease (COPD) is an inflammatory illness that prevents airflow from the lungs. Shortness of breath, wheezing, chest tightness, a persistent cough that produces mucus or not, recurrent colds, and sore throats are some of its early signs. On the other hand, asthma, usually referred to as bronchial asthma, is a respiratory condition that damages the lungs' airways. Breathlessness, heaviness in the chest, difficulty sleeping, and episodes of coughing or wheezing are some of its symptoms. Different devices that aid in the delivery of inhaled medicine are used to treat certain respiratory disorders. Devices for COPD and asthma, also known as pulmonary medication delivery devices, are used to treat respiratory disorders permanently or as a last resort. Devices for chronic obstructive pulmonary disease (COPD) and asthma help in medication delivery by turning drug suspensions or solutions into aerosolized particles. They are getting greatly popular worldwide. An increase in the prevalence of asthma and COPD, as well as technological developments and a rising elderly population, are the main drivers of market expansion. The demand for these devices has grown as a result of the significant rise in asthma prevalence and incidence, which has expanded the patient population.

US COPD and Asthma Devices Market is poised to grow at a sustainable CAGR for the next forecast year.